Status:
COMPLETED
19/5000 (SYNAPSOT21) Predictive Factors of Sleep Apnea Syndrome in Down Syndrome
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Down Syndrome
Sleep Apnea, Obstructive
Eligibility:
All Genders
18+ years
Brief Summary
The obstructive sleep apnea syndrome (OSAS) is frequently reported in subjects with trisomy 21. The consequences of this syndrome are expressed in various disorders such as cognitive and cardiovascula...
Detailed Description
The predictive factors for OSA that will be studied are: physical activity level, dentofacial disharmonies, blood parameters, motor disabilities, heart rate variability parameters measured during slee...
Eligibility Criteria
Inclusion
- Subjects with Down syndrome, able to practice physical activity all participants have received information all have signed the consent form
Exclusion
- pregnant women
- Pharmacological treatment altering autonomic nervous system (ANS)
- Contra-indication to physical exercise, such as atlanto-axial instability
Key Trial Info
Start Date :
November 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 11 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03445962
Start Date
November 15 2017
End Date
July 11 2019
Last Update
December 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble Alpes
Échirolles, France, 38130